-
May 2014
Expression of versican V3 by arterial smooth muscle cells alters tumor growth factor β (TGFβ)-, epidermal growth factor (EGF)-, and nuclear factor κB (NFκB)-dependent signaling pathways, creating a microenvironment that resists monocyte adhesion.
J Biol ChemKang I, Yoon DW, Braun KR, Wight TN -
May 2014
Avidity-dependent programming of autoreactive T cells in T1D.
PLoS OneDurinovic-Belló I, Gersuk VH, Ni C, Wu R, Thorpe J, Jospe N, Sanda S, Greenbaum CJ, Nepom GT -
May 2014
Type I interferons directly inhibit regulatory T cells to allow optimal antiviral T cell responses during acute LCMV infection.
J Exp MedSrivastava S, Koch MA, Pepper M, Campbell DJ -
May 2014
Urinary excretion of RAS, BMP, and WNT pathway components in diabetic kidney disease.
Physiol RepAfkarian M, Hirsch IB, Tuttle KR, Greenbaum CJ, Himmelfarb J, de Boer IH -
May 2014
NADPH oxidase-independent formation of extracellular DNA traps by basophils.
J ImmunolMorshed M, Hlushchuk R, Simon D, Walls AF, Obata-Ninomiya K, Karasuyama H, Djonov V, Eggel A, Kaufmann T, Simon HU, Yousefi S -
May 2014
Restoring the balance: immunotherapeutic combinations for autoimmune disease.
Dis Model MechSmilek DE, Ehlers MR, Nepom GT -
May 2014
Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection.
J VirolJohnston C, Zhu J, Jing L, Laing KJ, McClurkan CM, Klock A, Diem K, Jin L, Stanaway J, Tronstein E, Kwok WW, Huang ML, Selke S, Fong Y, Magaret A, Koelle DM, Wald A, Corey L -
May 2014
Regulatory T-cell homeostasis: steady-state maintenance and modulation during inflammation.
Immunol RevSmigiel KS, Srivastava S, Stolley JM, Campbell DJ -
May 2014
Increased density of intraepithelial mast cells in patients with exercise-induced bronchoconstriction regulated through epithelially derived thymic stromal lymphopoietin and IL-33.
J Allergy Clin ImmunolLai Y, Altemeier WA, Vandree J, Piliponsky AM, Johnson B, Appel CL, Frevert CW, Hyde DM, Ziegler SF, Smith DE, Henderson WR Jr, Gelb MH, Hallstrand TS -
May 2014
Low HERV-K(C4) copy number is associated with type 1 diabetes.
DiabetesMason MJ, Speake C, Gersuk VH, Nguyen QA, O'Brien KK, Odegard JM, Buckner JH, Greenbaum CJ, Chaussabel D, Nepom GT -
May 2014
Tissue integrity signals communicated by high-molecular weight hyaluronan and the resolution of inflammation.
Immunol ResRuppert SM, Hawn TR, Arrigoni A, Wight TN, Bollyky PL -
May 2014
FOXP3 and scurfy: how it all began.
Nat Rev ImmunolRamsdell F, Ziegler SF -
Apr 2014
Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for improving the accuracy of the risk classification of type 1 diabetes.
Diabetes CareSosenko JM, Skyler JS, Mahon J, Krischer JP, Greenbaum CJ, Rafkin LE, Beam CA, Boulware DC, Matheson D, Cuthbertson D, Herold KC, Eisenbarth G, Palmer JP, Type 1 Diabetes TrialNet and Diabetes Prevention Trial-Type 1 Study Groups. -
Apr 2014
Versican and the control of inflammation.
Matrix BiolWight TN, Kang I, Merrilees MJ -
Apr 2014
Costimulation modulation with abatacept in patients with recent-onset type 1 diabetes: follow-up 1 year after cessation of treatment.
Diabetes CareOrban T, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, Gottlieb PA, Greenbaum CJ, Marks JB, Monzavi R, Moran A, Peakman M, Raskin P, Russell WE, Schatz D, Wherrett DK, Wilson DM, Krischer JP, Skyler JS, Type 1 Diabetes TrialNet Abatacept Study Group.
